[1]
2013. Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study. Journal of Analytical Oncology. 2, 3 (Aug. 2013),  128–134. DOI:https://doi.org/10.6000/1927-7229.2013.02.03.1.